2 unknown, 1 completed, 1 recruiting. 2 Not applicable, 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Jiangnan University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients Probiotics, Placebo, Loperamide - HER2-positive Breast Cancer, Diarrhea Caused by Drug | Not applicable | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 308 | 2025-08-07 | 2026-06-17 |
| the Effect of Probiotics on Aging Population Bifidobacterium longum, A placebo made of starch - Debility | Not applicable | Unknown | Wuxi People's Hospital | 120 | 2021-06-01 | 2021-06-03 |
| The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC Coenzyme A Combined With Abiraterone, Abiraterone - Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | Unknown | Jiangnan University | 50 | 2021-03-18 | 2021-04-09 |
| Polaprezinc Treatment for Enzalutamide- or Abiraterone-resistant CRPC Polaprezinc group, Control group - Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | Completed | Jiangnan University | 12 | 2021-01-06 | 2023-07-11 |
Breast Neoplasms (1) · Diarrhea (1) · Frailty (1)
Control Groups (1) · Loperamide (1) · Probiotics (1) · abiraterone (1)
China (3)
Kan Hong, doctor (1) · Yong Q Chen, MD/PHD (1) · YongQuan Chen, MD (1)